UAE Blood Bags Market By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag v/s Transfer Bag), By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), By Material (PVC, PET, Others) By End User (Hospitals, Clinics, Ambulatory Surgical Center, Blood Banks, Others), By Region, Competition, Forecast & Opportunities, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 8.89 Million
CAGR (2026-2031)	7.93%
Fastest Growing Segment	Single Blood Bag
Largest Market	Dubai
Market Size (2031)	USD 14.05 Million

Market Overview

The UAE Blood Bags Market will grow from USD 8.89 Million in 2025 to USD 14.05 Million by 2031 at a 7.93% CAGR. Blood bags are sterile, flexible biomedical containers composed of biocompatible materials, designed for the safe collection, fractionation, storage, and transfusion of whole blood and its components. The market in the UAE is fundamentally propelled by the robust expansion of the national healthcare infrastructure and the rising prevalence of chronic hematological disorders that necessitate frequent transfusion therapies. Furthermore, vigorous government-led initiatives to encourage voluntary donations play a pivotal role in ensuring a steady supply of blood products, acting as a primary catalyst for sustained industry demand that is distinct from temporary market shifts.

According to Dubai Health, in 2024, first-time donors engaged through strategic national campaigns accounted for 54% of the total donor base, directly reflecting the growing requirement for high-quality collection units. However, a significant challenge that could impede market expansion is the stringent regulatory compliance regarding the manufacturing and disposal of medical-grade plastics, which imposes substantial operational costs and logistical complexities on suppliers operating within the region.

Key Market Drivers

The Rising Incidence of Road Traffic Accidents and Trauma Cases serves as a critical determinant for market volume, necessitating the immediate availability of blood bags for emergency transfusions. High-velocity impacts require rapid fluid resuscitation, directly influencing the inventory turnover of blood banks and trauma centers. This demand is particularly acute for durable, high-capacity bags capable of withstanding rapid pressure infusion during critical care scenarios. According to the Ministry of Interior, February 2025, the UAE recorded 6,062 injuries resulting from traffic accidents in 2024, creating a consistent, non-discretionary demand for emergency-grade blood storage solutions. Consequently, procurement strategies are increasingly prioritizing decentralized blood storage to ensure rapid deployment during critical trauma events.

Simultaneously, the Expansion of National Healthcare Infrastructure and Blood Bank Networks is fundamentally reshaping the market landscape by increasing the aggregate capacity for complex medical interventions. As hospital networks densify, the requirement for sophisticated blood collection and fractionation units scales proportionately to support oncological and surgical needs. According to PureHealth, February 2025, in the 'FY 2024 Financial Results', the group's emergency volumes grew by 31% year-on-year, underscoring the intensifying operational load on transfusion services. To sustain the inventory stability required for these expanding facilities, donor engagement has become integral; according to Dubai Health, June 2025, youth donors accounted for 41% of the donor base in 2024, ensuring a renewable supply chain for the growing number of transfusion-dependent procedures.

Download Free Sample Report

Key Market Challenges

Stringent regulatory compliance regarding the manufacturing and disposal of medical-grade plastics acts as a significant restraint on the UAE Blood Bags Market. Manufacturers are required to adhere to rigorous environmental safety protocols and biohazard disposal mandates, which necessitate substantial capital investment in specialized sterilization and waste management infrastructure. These extensive requirements elevate production costs and reduce profit margins, making it difficult for suppliers to price their products competitively while maintaining high quality. The financial strain is particularly acute for smaller market players, who struggle to absorb the costs associated with sustainable disposal mechanisms and advanced material sourcing.

The complexity of the market is further intensified by the frequent evolution of these guidelines, which creates a volatile operating environment. According to Mecomed, in 2024, the association shared more than 80 regulatory circulars to keep member companies updated on regional changes. This statistic highlights the administrative burden placed on suppliers, who must continuously allocate resources to track and implement shifting compliance requirements. The necessity to constantly adapt to such a high volume of regulatory updates diverts focus from strategic expansion and innovation, thereby directly hampering the overall growth momentum of the industry.

Key Market Trends

The Rapid Expansion of Private Umbilical Cord Blood Banking Services is emerging as a defining trend, driven by increasing parental awareness regarding the long-term therapeutic potential of stem cells for regenerative medicine. This sector is moving beyond niche adoption, supported by the establishment of internationally accredited local facilities that eliminate the need for overseas storage. The robust development of this bio-banking infrastructure is validating the region's capabilities in handling sensitive cellular products, thereby fostering greater consumer trust and uptake. According to Middle East Health, May 2025, in the article 'Abu Dhabi facilities achieve first AABB accreditation in UAE for haematopoietic cell collection', the Abu Dhabi Stem Cells Center and Yas Clinic became the first healthcare institutions in the country to secure AABB accreditation for haematopoietic progenitor cell collection, signaling a significant maturity in the regional ecosystem for stem cell preservation and banking.

Simultaneously, the Adoption of Advanced X-Ray Blood Irradiation for Pathogen Inactivation is gaining critical momentum, specifically to address the complex safety requirements of the flourishing medical tourism sector. Unlike standard emergency transfusions, the planned high-complexity procedures sought by international patients, such as organ transplants and immune-suppressed therapies, strictly mandate the use of irradiated blood components to prevent Transfusion-Associated Graft-Versus-Host Disease. This specific clinical demand is compelling blood centers to integrate sophisticated irradiation technologies into their processing workflows. According to Aletihad News Center, February 2025, in the article 'Cleveland Clinic Abu Dhabi reports 35% growth in international patient visits in 2024', the hospital recorded a 35 percent increase in international patient visits, a surge that directly intensifies the requirement for specialized, pathogen-inactivated blood products to support these high-risk medical interventions.

Segmental Insights

Based on recent market assessments, the Single Blood Bag segment is identified as the fastest-growing category within the UAE Blood Bags Market. This rapid expansion is primarily driven by the cost-effectiveness of these units for routine whole blood collection and the increasing volume of voluntary donations supported by the Ministry of Health and Prevention. Healthcare facilities extensively utilize single bags for their efficiency in general storage and transport, particularly for emergency settings where immediate whole blood availability is critical. Consequently, the demand for these economical collection solutions continues to outpace other segments across the Emirates.

Regional Insights

Dubai maintains the leading position in the UAE blood bags market due to its extensive healthcare infrastructure and high surgical case volumes. The region's dominance is supported by the Dubai Health Authority (DHA), which enforces rigorous blood safety standards and manages key facilities such as the Dubai Blood Donation Centre. This centralized approach ensures a consistent demand for collection and storage products to support trauma care and elective procedures. Additionally, the high concentration of accredited hospitals serving medical tourists further solidifies Dubai as the primary driver of market demand within the Emirates.

Recent Developments

• In June 2025, Dubai Health solidified a major collaborative effort by recognising 43 strategic partners for their role in the "My Blood, for My Country" campaign. This initiative, organised in conjunction with government bodies and private institutions, was designed to secure a steady supply of blood units for public and private healthcare facilities across the emirate. The collaboration focused on expanding the donor base and ensuring the availability of blood bags for critical treatments, including for the Thalassemia Centre. This large-scale partnership highlights the critical role of corporate and institutional cooperation in driving the volume and sustainability of the UAE blood bags market.
• In August 2024, the Abu Dhabi Health Services Company (SEHA) launched a state-of-the-art X-ray blood irradiator at the Abu Dhabi Blood Bank Services. The new RS 3400 system employs advanced X-ray technology to treat blood bags, significantly reducing the risk of Transfusion-Associated Graft-Versus-Host Disease (TA-GVHD) for immunocompromised patients. This product launch enhances the processing capabilities of the blood bank, allowing for a faster irradiation cycle and increased capacity for treating blood units. The deployment of this technology underscores the company's commitment to adopting innovative medical devices that improve the safety and efficacy of blood bag products used in transfusions.
• In February 2024, PureHealth announced that its subsidiary, Abu Dhabi Blood Bank Services (ADBBS), achieved formal accreditation from the Association for the Advancement of Blood and Biotherapies (AABB). This international recognition validates the company's adherence to rigorous global standards in the collection, testing, processing, and storage of blood components. The accreditation directly impacts the UAE blood bags market by ensuring that the handling and utilisation of blood bags within the network meet the highest quality and safety benchmarks. This milestone reinforces the position of ADBBS as a leading entity in the regional blood management supply chain.
• In January 2024, Emirates Health Services (EHS) introduced a robotic blood-drawing device at its healthcare facilities, marking a technological breakthrough in the UAE blood collection sector. Unveiled during a major regional healthcare exhibition, this automated system utilises artificial intelligence and infrared imaging to enhance the precision and efficiency of venipuncture. The integration of this technology aims to reduce patient waiting times and improve the quality of blood samples collected in blood bags. This launch represents a significant step in modernising the infrastructure supporting the UAE blood bags market, ensuring higher standards of safety and operational efficiency in donor management.

Key Market Players

• Terumo Middle East FZE
• Fresenius Medical Care Middle East FZ LLC
• CytoMed Therapeutics Limited
• Teleflex UAE
• MacoPharma UAE
• Grifols International S.A. Dubai R.O.

By Product Type	By Type	By Volume	By Material	By End User	By Region
Single Blood Bag Double Blood Bag Triple Blood Bag Quadruple Blood Bag Penta Blood Bag	Collection Bag v/s Transfer Bag	100ml 150ml 250ml 300ml 350ml 400ml 450ml 500ml	PVC PET Others	Hospitals Clinics Ambulatory Surgical Center Blood Banks Others	Dubai Abu Dhabi Sharjah Rest of UAE

Report Scope:

In this report, the UAE Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• UAE Blood Bags Market, By Product Type:

• Single Blood Bag
• Double Blood Bag
• Triple Blood Bag
• Quadruple Blood Bag
• Penta Blood Bag

• UAE Blood Bags Market, By Type:

• Collection Bag v/s Transfer Bag

• UAE Blood Bags Market, By Volume:

• 100ml
• 150ml
• 250ml
• 300ml
• 350ml
• 400ml
• 450ml
• 500ml

• UAE Blood Bags Market, By Material:

• PVC
• PET
• Others

• UAE Blood Bags Market, By End User:

• Hospitals
• Clinics
• Ambulatory Surgical Center
• Blood Banks
• Others

• UAE Blood Bags Market, By Region:

• Dubai
• Abu Dhabi
• Sharjah
• Rest of UAE